Interventions to Reduce Cancer Screening Inequities A group of patients and patient advocacy organisations published a promising multistep strategy to reduce cancer screening inequalities In […]

<strong>First Immunotherapy Drug Durvalumab Plus Chemotherapy Approved in Europe for Advanced Biliary Cancer</strong> On 21 December the European Commission (EC) approved the use of durvalumab (Imfinzi ®) plus chemotherapy (gemcitabine plus cisplatin) as the first […]

<strong>Trastuzumab Deruxtecan Approved as Second-line Treatment in Europe For Patients With HER2-positive Advanced Gastric Cancer</strong> On December 19th the European Commission (EC) approved the use of trastuzumab deruxtecan (Enhertu ®) plus chemotherapy (gemcitabine plus cisplatin) […]

CRC Patients and caregivers, join the European community of COLONTOWN!

COLONTOWN is an international community of colorectal cancer patients and their […]

October and November were busy months for our Swedish member […]

Would you like to know how and where patient engagement is happening in R&D? Would you like to see an objective comparison between Europe and Japan? National Cancer Centre Japan needs your support to promote t […]

For the 2022 edition, we received five great projects from Belgium, France, Italy and Portugal, respectively. Results were tight among the jury. One project, however, exceeded the others with the highest score: […]

The […]

Digestive Health Community Support for the Proposed EU Cancer Screening Recommendations

<strong>Nutrition Position Paper</strong> Nutritional intervention is essential to cancer treatments. It can reduce hospitalisation length and treatment-related toxicity while improving […]

A study recently published in the New England Journal of Medicine created much buzz in mid-October, questioning the usefulness of colonoscopies as a screening tool for colorectal cancer (CRC).

The […]

DiCE participated in three exciting days of innovative and inspiring live workshops. The patient & people-centric sessions offered the chance to join small groups of like-minded individuals and co-create on a […]

Next year might be busier than initially expected as the European Commission is rumoured to have postponed the publication of one of the most awaited proposals – the revision of the general pharmaceutical l […]

Tzav Meni’a, our Associate Member, based in Israel, has recently implemented two new projects – A mentorship programme to support patients and carers and the production […]

At DiCE, we strongly believe in cooperation and working together, which is why it was our pleasure to join UEG at their yearly congress in Vienna this year.

DiCE was present to raise awareness and create […]

Encouraging results on the use of immunotherapy for patients with deficient mismatch repair colon cancer were presented at the ESMO Congress 2022 in Paris.

Mismatch repair (MMR) genes are involved in repairing […]